Peisen F, Gerken A, Dahm I, Nikolaou K, et al. Pre-treatment 18F-FDG-PET/CT parameters as biomarkers for progression free survival, best overall response and overall survival in metastatic melanoma patients undergoing first-line immunotherapy. PLoS One 2024;19:e0296253.
PMID: 38180971